Results 81 to 90 of about 286,873 (209)

Long-term follow-up and treatment of lamellar hole-associated epiretinal proliferation presenting with exudative perivascular anomalous complex

American Journal of Ophthalmology Case Reports
Purpose: To report a patient with lamellar hole-associated epiretinal proliferation (LHEP), presenting with exudative perifoveal vascular anomalous complex (ePVAC), who was initially treated with intravitreal anti-vascular endothelial growth factor (anti-
Gy. Dósa, Joanne M. Fuller, Madeleine Zetterberg, Martin Breimer, Lada Kalaboukhova   +4 more
doaj   +1 more source

Adult Coats’ Disease Successfully Managed with the Dexamethasone Intravitreal Implant (Ozurdex®) Combined with Retinal Photocoagulation

Case Reports in Ophthalmology, 2012
Purpose: To report a case of Coats’ disease managed with the dexamethasone intravitreal implant Ozurdex® (Allergan, Inc., Irvine, Calif., USA) combined with retinal photocoagulation.
Sebastián Martínez-Castillo, Roberto Gallego-Pinazo, Rosa Dolz-Marco, Cristina Marín-Lambíes, Manuel Díaz-Llopis   +4 more
doaj   +1 more source

Advanced Corneal Hydrogels: From Passive Replacement to Active Regeneration and Intelligent Interaction

Advanced Science, Volume 13, Issue 19, 2 April 2026.
This review charts the evolution of corneal hydrogels from passive replacements to active and intelligent systems, evaluating natural and synthetic materials while addressing design challenges such as transparency and strength. Advanced applications such as scarless wound healing, three‐dimensional bioprinting, and smart wearables are highlighted to ...
Xinwei Wang, Wen Zhou, Haotian Xue, Wenjun Xue, Guangping Gao, Bing Zhu, Hongyuan Song, Qingqiang Xu, Jing Zhao, Wei Shen   +9 more
wiley   +1 more source

The Effects of Intravitreal Ranibizumab Aflibercept or Dexamethasone Implant Injections on Intraocular Pressure Changes

, 2018
Background: The aim of this study was to compare the alterations in intraocular pressure (IOP) values during the early postoperative period after intravitreal ranibizumab, aflibercept, or dexamethasone implant ...
Icel, Erel, Karakurt, Yucel, Yilmaz, Hayati, Ucak, Turgay, Agcayazi, Burcu, Tasli, Gamze   +5 more
core   +1 more source

Intravitreal Injection of Ozurdex® Implant in Patients with Persistent Diabetic Macular Edema, with Six-Month Follow-Up

Ophthalmology and Eye Diseases, 2016
Aim To evaluate the efficacy of intravitreal dexamethasone injections in diabetic macular edema (DME). Methods A 700 μg slow-release intravitreal dexamethasone implant (Ozurdex®) was placed in the vitreal cavity of 17 patients (19 eyes) affected with ...
Fernanda Pacella, Adriana Francesca Ferraresi, Paolo Turchetti, Tommaso Lenzi, Rosalia Giustolisi, Andrea Bottone, Valeria Fameli, Maria Rosaria Romano, Elena Pacella   +8 more
doaj   +1 more source

Coat-s-like exudation in rhodopsin retinitis pigmentosa: successful treatment with an intravitreal dexamethasone implant

, 2014
Purpose: Role of intravitreal injection of dexamethasone implant (Ozurdex) for refractory macular thickening.Methods: A case report of a 13-year-old boy with Rhodopsin-positive, CRB1-negative retinitis pigmentosa presenting with Coat's-like exudative ...
A J Lotery, Patil, L., L Patil, Lotery, A. J.   +3 more
core   +1 more source

Longstanding refractory pseudophakic cystoid macular edema resolved using intravitreal 0.7 mg dexamethasone implants

Clinical Ophthalmology, 2013
Troels Brynskov,1,2 Caroline Schmidt Laugesen,1 Jakob Halborg,1 Henrik Kemp,1 Torben Lykke Sørensen1,21Department of Ophthalmology, Copenhagen University Hospital Roskilde, Roskilde, Denmark; 2Faculty of Health Sciences, University of Copenhagen ...
Brynskov T, Laugesen CS, Halborg J, Kemp H, Sørensen TL   +4 more
doaj  

Resolution of Persistent Cystoid Macular Edema due to Central Retinal Vein Occlusion in a Vitrectomized Eye following Intravitreal Implant of Dexamethasone 0.7 mg

Case Reports in Ophthalmology, 2012
We report the case of a 62-year-old woman with a history of vitreoretinal surgery for vitreous hemorrhage secondary to central retinal vein occlusion (CRVO).
Michele Reibaldi, Andrea Russo, Marco Zagari, Mario Toro, Vittorio De Grande, Valentina Cifalinò, Stefania Rametta, Salvatore Faro, Antonio Longo   +8 more
doaj   +1 more source

Incomplete scleral penetration of dexamethasone (Ozurdex) intravitreal implant

BMJ Case Reports, 2018
Ozurdex (Allergan, Irvine, California, USA) is a biodegradable sustained release intravitreal implant containing 0.7 mg dexamethasone in a solid polymer drug delivery system. In the UK, it is approved for use in patients with macular oedema secondary to retinal vein occlusion, diabetic maculopathy and non-infectious uveitis.
Thomas, Sherman, Vasant, Raman
openaire   +3 more sources

Cystoid Macular Edema Associated With Juvenile Idiopathic Arthritis Resolved by a Dexamethasone Intravitreal Implant

, 2014
Uveitis, glaucoma, and cystoid macular edema frequently develop in patients with juvenile idiopathic arthritis. The authors describe a case of cystoid macular edema associated with juvenile idiopathic arthritis that had not responded to intravitreal ...
Hepsen, Ibrahim F., Yüksel Totan, Dervisogullari, Mehmet S., Fatma B. Guragaç, Ibrahim F. Hepsen, Mehmet S. Dervisogullari, Guragac, Fatma B., Guler, Emre, Tenlik, Aylin, Aylin Tenlik, Totan, Yuksel, Emre Güler   +11 more
core   +1 more source